[1] |
中国医师协会内分泌代谢科医师分会. 多囊卵巢综合征诊治内分泌专家共识[J]. 中华内分泌代谢杂志, 2018, 34(1):1-7.
|
[2] |
LEGRO R S, ARSLANIAN S A, EHRMANN D A, et al. Diagnosis and treatment of polycystic ovary syndrome:an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab, 2013, 98(12):4565-4592.
DOI
URL
|
[3] |
CONWAY G, DEWAILLY D, DIAMANTI-KANDARAKIS E, et al. The polycystic ovary syndrome:a position statement from the European Society of Endocrinology[J]. Eur J Endocrinol, 2014, 171(4):P1-P29.
DOI
URL
|
[4] |
WITCHEL S F, OBERFIELD S, ROSENFIELD R L, et al. The diagnosis of polycystic ovary syndrome during adolescence[J]. Horm Res Paediatr, 2015.
|
[5] |
中华医学会妇产科学分会内分泌学组及指南专家组. 多囊卵巢综合征中国诊疗指南[J]. 中华妇产科杂志, 2018, 53(1):2-6.
|
[6] |
LIZNEVA D, GAVRILOVA-JORDAN L, WALKER W, et al. Androgen excess:investigations and management[J]. Best Pract Res Clin Obstet Gynaecol, 2016, 37:98-118.
DOI
URL
|
[7] |
赵丽, 蔡昭炜, 李雪玲, 等. 抗缪勒氏管激素联合性激素检查在诊断多囊卵巢综合征的价值[J]. 现代诊断与治疗, 2020, 31(2):269-270.
|
[8] |
ESCOBAR-MORREALE H F. Polycystic ovary syndrome:definition,aetiology,diagnosis and treatment[J]. Nat Rev Endocrinol, 2018, 14(5):270-284.
DOI
URL
|
[9] |
KEEVIL B G, ADAWAY J. Assessment of free testosterone concentration[J]. J Steroid Biochem Mol Biol, 2019, 190:207-211.
DOI
URL
|
[10] |
VERMEULEN A, VERDONCK L, KAUFMAN J M. A critical evaluation of simple methods for the estimation of free testosterone in serum[J]. J Clin Endocrinol Metab, 1999, 84(10):3666-3672.
DOI
URL
|
[11] |
叶雅萍, 李萍. 性激素结合球蛋白在生殖医学中的应用研究进展[J]. 生殖医学杂志, 2022, 31(2):273-277.
|
[12] |
KEEVIL B G, ADAWAY J, FIERS T, et al. The free androgen index is inaccurate in women when the SHBG concentration is low[J]. Clin Endocrinol(Oxf), 2018, 88(5):706-710.
DOI
URL
|
[13] |
O'REILLY M W, TAYLOR A E, CRABTREE N J,et al. Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome:the utility of serum androstenedione[J]. J Clin Endocrinol Metab, 2014, 99(3):1027-1036.
DOI
URL
|
[14] |
CHEN F, CHEN M, ZHANG W, et al. Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS[J]. J Ovarian Res, 2021, 14(1):32.
DOI
PMID
|
[15] |
牛静云, 侯丽辉, 寇丽辉, 等. 不同高雄激素血症表型多囊卵巢综合征患者临床特征分析[J]. 实用妇产科杂志, 2018, 34(4):286-290.
|
[16] |
GOODMAN N F, COBIN R H, FUTTERWEIT W, et al.. American Association of Clinical Endocrinologists,American College of Endocrinology,and Androgen Excess and PCOS Society disease state clinical review:guide to the best practices in the evaluation and treatment of polycystic ovary syndrome-part 1[J]. Endocr Pract, 2015, 21(11):1291-1300.
DOI
URL
|
[17] |
GOODARZI M O, CARMINA E, AZZIZ R. DHEA, DHEAS and PCOS[J]. J Steroid Biochem Mol Biol, 2015, 145:213-225.
DOI
URL
|
[18] |
夏曦, 邓玉颖, 顾俊婕, 等. 超高压液相色谱-质谱联用技术联合分析血清睾酮和硫酸脱氢表雄酮提高多囊卵巢综合征的诊断率[J]. 中华内分泌代谢杂志, 2018, 34(2):136-140.
|
[19] |
CAO Z, LU Y, CONG Y, et al. Simultaneous quantitation of four androgens and 17-hydroxyprogesterone in polycystic ovarian syndrome patients by LC-MS/MS[J]. J Clin Lab Anal, 2020, 34(12):e23539.
|
[20] |
TOSI F, FIERS T, KAUFMAN J M, et al. Implications of androgen assay accuracy in the phenotyping of women with polycystic ovary syndrome[J]. J Clin Endocrinol Metab, 2016, 101(2):610-618.
DOI
PMID
|
[21] |
KEEVIL B. Steroid mass spectrometry for the diagnosis of PCOS[J]. Med Sci(Basel), 2019, 7(7):78.
|
[22] |
AMBROZIAK U, KPCZYSKA-NYK A, KURYLOWICZ A, et al. LC-MS/MS improves screening towards 21-hydroxylase deficiency[J]. Gynecol Endocrinol, 2015, 31(4):296-300.
DOI
PMID
|
[23] |
HANDELSMAN D J, WARTOFSKY L. Requirement for mass spectrometry sex steroid assays in the Journal of Clinical Endocrinology and Metabolism[J]. J Clin Endocrinol Metab, 2013, 98(10):3971-3973.
DOI
URL
|
[24] |
WIERMAN M E, AUCHUS R J, HAISENLEDER D J, et al. Editorial:the new instructions to authors for the reporting of steroid hormone measurements[J]. Mol Endocrinol, 2014, 28(12):1917.
DOI
URL
|
[25] |
TEEDE H J, MISSO M L, COSTELLO M F, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome[J]. Hum Reprod, 2018, 33(9):1602-1618.
DOI
URL
|
[26] |
ZHAO M, BAKER S D, YAN X, et al. Simultaneous determination of steroid composition of human testicular fluid using liquid chromatography tandem mass spectrometry[J]. Steroids, 2004, 69(11-12):721-726.
PMID
|
[27] |
OLIVEIRA L R, LONGUI C A, GUARAGNA-FILHO G, et al. Androgens by immunoassay and mass spectrometry in children with 46,XY disorder of sex development[J]. Endocr Connect, 2020, 9(11):1085-1094.
DOI
PMID
|
[28] |
SHIRAISHI S, LEE P W, LEUNG A, et al. Simultaneous measurement of serum testosterone and dihydrotestosterone by liquid chromatography-tandem mass spectrometry[J]. Clin Chem, 2008, 54(11):1855-1863.
DOI
PMID
|
[29] |
YARROW J F, BECK D T, CONOVER C F, et al. Invalidation of a commercially available human 5α-dihydrotestosterone immunoassay[J]. Steroids, 2013, 78(12-13):1220-1225.
DOI
PMID
|
[30] |
KEEFE C C, GOLDMAN M M, ZHANG K, et al. Simultaneous measurement of thirteen steroid hormones in women with polycystic ovary syndrome and control women using liquid chromatography-tandem mass spectrometry[J]. PLoS One, 2014, 9(4):e93805.
DOI
URL
|
[31] |
FANELLI F, BELLUOMO I, DI LALLO V D, et al. Serum steroid profiling by isotopic dilution-liquid chromatography-mass spectrometry:comparison with current immunoassays and reference intervals in healthy adults[J]. Steroids, 2011, 76(3):244-253.
DOI
URL
|
[32] |
医疗器械监督管理条例[EB/OL].(2021-03-19)[2021-04-01]. https://www.nmpa.gov.cn/xxgk/fgwj/flxzhfg/20210319202057136.html.
|
[33] |
Clinical and Laboratory Standards Institute. Liquid chromatography-mass spectrometry methods[S]. C62-A,CLSI, 2014.
|
[34] |
Clinical and Laboratory Standards Institute. Defining, establishing, and verifying reference intervals in the clinical laboratory[S]. EP28-A3c,CLSI, 2010.
|